Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Cancer

Clinical trial NCT00004037 · TERMINATED

Trial details

NCT number: NCT00004037
Sponsor: Gynecologic Oncology Group
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Primary Peritoneal Cavity Cancer

Start date: 1998-06-01
Primary completion: 2003-04-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.